Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Streamed
On Demand
Back
Favorite
Facebook
Tweet
Print
Michael Silverman, MD
Medical Director
Acurx Pharmaceuticals, LLC
Disclosure(s): Acurx: Advisor/Consultant
Poster(s):
(P-1109) A phase 2, randomized, double-blind study of ibezapolstat compared with vancomycin for the treatment of
Clostridioides difficile
infection: clinical and microbiome evaluation
Friday, October 18, 2024
12:15 PM – 1:30 PM
US PT
